What Challenges Exist in Targeting Enhanced Circulation?
One of the major challenges in targeting enhanced circulation is the development of resistance to anti-angiogenic therapies. Tumors can adapt by finding alternative pathways to promote angiogenesis or by becoming more aggressive. Additionally, inhibiting angiogenesis can sometimes lead to increased hypoxia (low oxygen levels), which can make the tumor more resistant to other treatments like chemotherapy and radiotherapy.
